Clover Health

Revenue climbed about 40 percent over the past year as more seniors signed up for Clover's plans. That is fast growth for a health insurer, a business most people assume moves slowly. The company also repeated its full year 2026 targets on April 1st, so management is standing behind the plan.

Clover has been building Clover Assistant since 2014, and it now sells that same technology to outside doctors through its Counterpart Health arm. Catching a problem like diabetes or kidney disease early costs far less than treating it in a hospital. That is how an insurer turns better care into better money.

Chief Financial Officer Peter Kuipers is stepping down effective March 30th, 2026, staying on as an advisor only through April 24th. The finance leader of Clover's insurance plan is taking over on an interim basis. The company says there was no disagreement, but swapping your top money person mid year is never ideal timing.

This stock has a beta of 2.48, meaning it tends to move roughly two and a half times as hard as the overall market in both directions. Profit margins are still slightly negative at about negative 2.6 percent. If medical costs jump or growth cools, the share price can fall fast.